Report Library
All Reports
C&EN Supplement - The 2015 Top 20 Drugs in the Pipeline
October 08, 2015
BioMedTracker is featuring content from respected outside sources to augment its original report content. This article was originally
published by C&EN in September 2015.
Chemical & Engineering News (C&EN) is a weekly magazine published by the American Chemical Society. C&EN covers science and
technology, business and industry, government and policy, education, and employment aspects of the chemistry field.
"The 2015 Top 20 Drugs In The Pipeline" article published by C&EN identifies promising new drugs in clinical development. These drugs look poised to win approval in the coming years and have a profound effect on human health, from rare diseases to common cancers. This article also includes insight on the Major Depressive Disorder (MDD) pipeline from Dr. Edny Inui, BioMedTracker's Lead CNS Analyst.
For our disclosures, please read the BioMedTracker Research Standards.
"The 2015 Top 20 Drugs In The Pipeline" article published by C&EN identifies promising new drugs in clinical development. These drugs look poised to win approval in the coming years and have a profound effect on human health, from rare diseases to common cancers. This article also includes insight on the Major Depressive Disorder (MDD) pipeline from Dr. Edny Inui, BioMedTracker's Lead CNS Analyst.
For our disclosures, please read the BioMedTracker Research Standards.
| Disease Group Covered: |
Autoimmune/immunology
Hematology Infectious Disease Metabolic Neurology Oncology Ophthalmology Psychiatry Respiratory |
| Indications Covered: |
Ischemic Stroke
Wound Healing |
Additional Resources: